MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts

"MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts". The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect.

Description-

Summary

Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, affecting approximately 1.0% of the world population. Presently there is a huge presence of unmet patient needs for both the treatment and diagnosis.

Focus for the treatment paradigm has now shifted towards the early detection and diagnosis of the disease, which will allow physicians to begin aggressive treatment of the condition, minimizing the associated complications and tissue damage.


Global sales of $347m in 2016 and estimated growth rate of 2% during the forecast period; the emerging markets: Brazil, Canada, China and Mexico are expected to show the fastest growth.

Key market drivers -
- Increasing prevalence of autoimmune diseases globally including RA
- Emerging biomarkers and advancement in technology for the early diagnosis of RA
- Increasing adoption of anti-cyclic citrullinated peptide (anti-CCP) antibody test
- Rising demand for lab automation

Key market barriers -
- Limited sensitivity of existing RA diagnostic tests
- Healthcare cost-cutting and reduced reimbursement in major markets

Highlights

Key Questions Answered

- What is the current and future RA testing market outlook in the developed and emerging markets? What trends are affecting the global market?
- What is the competitive landscape and who are major players in the RA testing space?


- What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the RA tests currently on the market? How will emerging technologies such as POC assays fulfil these unmet needs?
- What are the key products and pipelines in the RA testing market?
- What are the challenges and barriers that have hindered widespread adoption of RA tests in different regions?

Scope

- Competitive assessment: Currently marketed RA diagnostic products and evolving competitive landscape
- In-depth analysis of unmet needs and adoption trends of different RA diagnostic tests
- Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
- Pipeline analysis: Emerging products and technologies.
- Annualized total RA testing market revenue by segment and market outlooks by country from 2013-2022.
- Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

For More Information Kindly Contact:

ResearchMoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States
866-997-4948 (Us-Canada Toll Free),
+1-518-621-2074,

Email to: sales@researchmoz.us

Comments

Popular posts from this blog

Global Automated Fingerprint Identification System Market 2016-2020

Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019

Global Handling and Lifting Equipment Industrial Trend and Market Demand 2016-2020